Senseonics Holdings (SENS) Debt to Equity (2014 - 2024)

Name: Senseonics Holdings (SENS) Debt to Equity (2014 - 2024) | Business Quant
Creator: Business Quant

Senseonics Holdings (SENS) reported Debt to Equity of $0.01 for Q1 2024, up 169.28% on a QoQ basis from -$0.01 in Q4 2022.

Senseonics Holdings (SENS) has 8 years of Debt to Equity data on file, last reported at $0.01 in Q1 2024.

Quarterly Debt to Equity changed N/A year-over-year to $0.01 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $0.01 (changed N/A YoY) and the FY2022 annual result came in at -$0.01, changed N/A from the prior year.
Debt to Equity grew to $0.01 in Q1 2024 per SENS's latest filing, from -$0.01 in the prior quarter.
Across five years, Debt to Equity topped out at $0.03 in Q2 2022 and bottomed at -$0.02 in Q3 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	0.65
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	0.64
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	0.57
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	0.42
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	0.06
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	0.95
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	0.27
10	Senseonics Holdings	316.18 Mn	251.85 Mn	6.94 Mn	-

Download Data 🔒